콘텐츠로 건너뛰기
Remedi Logo Remedi Logo
  • Company
    • CEO’s greeting
    • About us
    • History
    • Member
    • Partnerships
    • Address
  • R&D
    • Key technology
      • Understanding of technology
      • IDDT Platform
      • Application
      • Cosmeceutical Peptide
    • CRO service
    • OEM/ODM service
  • Products
    • DR.REM+
    • Dermavis
    • DualPep
  • NEWS
    • Notice
    • News
    • Certification
    • Publiciation
    • Patents
    • Contact us
  • Company
    • CEO’s greeting
    • About us
    • History
    • Member
    • Partnerships
    • Address
  • R&D
    • Key technology
      • Understanding of technology
      • IDDT Platform
      • Application
      • Cosmeceutical Peptide
    • CRO service
    • OEM/ODM service
  • Products
    • DR.REM+
    • Dermavis
    • DualPep
  • NEWS
    • Notice
    • News
    • Certification
    • Publiciation
    • Patents
    • Contact us

Notice

Leading the biomarket with human-derived cell-penetrating peptides

HOME News
  • All
  • Notice
  • News

제2기 정기주주총회 소집통지서

저희 주식회사 레메디는 당사 정관 30조에 의거 아래와 같이 정기주주총회를 개최하고자 하오니 바쁘시더라도 참석하여 주시...

2022.03.02 Notice

  • First
  • «
  • 1
  • 2

R&D

Products

To top

REMEDI Co., Ltd.

Address.
#D707, 30, Songdomirae-ro, Yeonsu-gu, Incheon, 21990, Republic of Korea
Tel.
+82-32-819-3399
Edisbiothec

Copyrights (C) REMEDI Co., Ltd. All rights reserved.

Contact us